FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
The US Food and Drug Administration has issued a new warning about the possible risk of secondary cancers in cancer patients who have been treated with a form of immunotherapy called chimeric antigen receptor T-cell, or CAR-T cell, therapy. The FDA sent notification letters this week and last week…
#fda #bcma #cd19 #yescarta #medicationguide #joshuabrody #tischcancerinstitute #mountsinai #petermarks #marks